Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$5.11 - $8.76 $134,668 - $230,861
-26,354 Reduced 29.0%
64,519 $559,000
Q4 2023

Feb 13, 2024

BUY
$4.7 - $9.87 $427,103 - $896,916
90,873 New
90,873 $595,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $300,422 - $422,366
32,869 Added 114.65%
61,539 $615,000
Q2 2023

Aug 14, 2023

SELL
$12.09 - $15.0 $27.3 Million - $33.9 Million
-2,261,949 Reduced 98.75%
28,670 $356,000
Q1 2023

May 11, 2023

SELL
$12.99 - $16.48 $843,038 - $1.07 Million
-64,899 Reduced 2.76%
2,290,619 $32.1 Million
Q4 2022

Feb 13, 2023

SELL
$12.5 - $24.78 $19.3 Million - $38.2 Million
-1,542,833 Reduced 39.58%
2,355,518 $33.7 Million
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $30.9 Million - $45.6 Million
1,501,611 Added 62.65%
3,898,351 $99.5 Million
Q2 2022

Aug 12, 2022

BUY
$26.05 - $37.48 $62.4 Million - $89.8 Million
2,396,740 New
2,396,740 $68.1 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $552M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.